Steris (NYSE:STE) will be announcing its earnings results before the market opens on Wednesday, February 7th. Analysts expect the company to announce earnings of $1.07 per share for the quarter.
Shares of Steris (STE) opened at $88.08 on Tuesday. Steris has a 1 year low of $65.26 and a 1 year high of $93.71. The company has a quick ratio of 2.18, a current ratio of 2.80 and a debt-to-equity ratio of 0.48. The company has a market cap of $7,705.74, a PE ratio of 52.43 and a beta of 1.22.
Several equities research analysts recently commented on STE shares. Zacks Investment Research upgraded shares of Steris from a “hold” rating to a “buy” rating and set a $101.00 price objective on the stock in a research report on Monday, October 9th. KeyCorp reiterated a “buy” rating and issued a $91.00 price objective on shares of Steris in a research report on Tuesday, October 17th. Raymond James Financial reiterated a “market perform” rating and issued a $100.00 price objective on shares of Steris in a research report on Wednesday, January 3rd. Finally, TD Securities boosted their price objective on shares of Steris from C$14.00 to C$16.00 and gave the stock a “buy” rating in a research report on Thursday, November 9th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $80.00.
In other Steris news, VP John Adam Zangerle sold 3,650 shares of the company’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $88.00, for a total value of $321,200.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Sudhir K. Pahwa sold 2,000 shares of the company’s stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $92.09, for a total transaction of $184,180.00. The disclosure for this sale can be found here. 2.55% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: “Steris (STE) to Release Quarterly Earnings on Wednesday” was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/06/steris-ste-to-release-quarterly-earnings-on-wednesday.html.
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.